Xyzal

Product manufactured by Ucb Farchim S.a.

Application Nr Approved Date Route Status External Links
NDA022064 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Xyzal Is A Histamine H1‑receptor Antagonist Indicated For: The Relief Of Symptoms Associated With Seasonal And Perennial Allergic Rhinitis (1.1, 1.2) The Treatment Of The Uncomplicated Skin Manifestations Of Chronic Idiopathic Urticaria (1.3) 1.1 Seasonal Allergic Rhinitis Xyzal® Is Indicated For The Relief Of Symptoms Associated With Seasonal Allergic Rhinitis In Adults And Children 2 Years Of Age And Older. 1.2 Perennial Allergic Rhinitis Xyzal Is Indicated For The Relief Of Symptoms Associated With Perennial Allergic Rhinitis In Adults And Children 6 Months Of Age And Older. 1.3 Chronic Idiopathic Urticaria Xyzal Is Indicated For The Treatment Of The Uncomplicated Skin Manifestations Of Chronic Idiopathic Urticaria In Adults And Children 6 Months Of Age And Older.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Levocetirizine Dihydrochloride LEVOCETIRIZINE DIHYDROCHLORIDE ZINC19364230

Comments